EL NUEVO DIARIO, INTERNATIONAL.- The United States Food and Drug Administration, for its acronym in English FDA, has proposed a new annual vaccine against covid but adapted to new strains of the disease.
This with the aim of making vaccination against covid-19 similar to the annual flu vaccine.
The project under the new, more simplified system, is that the FDA’s Vaccine and Related Biological Products Advisory Committee (VRBPAC) would meet every June to evaluate and discuss the most dangerous coronavirus strains.
Manufacturers would then update their vaccines each September to target the strain or strains that epidemiologists predict are worrisome.
Such a change would make the United States’ national management approach for Covid-19 similar to how it is done with the flu.
What is the OBJETIVE?
The goal is to simplify what has become a complicated web of primary vaccination courses, boosters, bivalent injections, and recommendations that vary by age group and immune status.
Under the current system, people seeking to be vaccinated against covid-19 must receive two injections of the original vaccine weeks apart.
Then, two months later, they can get a bivalent booster shot, so this new plan advises almost everyone to get their last shot, once a year, in the fall.
